ArticleFrontiers in endocrinology2022

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study.

Juan Bañares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.